Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk  | Very High  | Very High  | 
Rating  | -  | -  | 
Min SIP Amount  | ₹100  | ₹100  | 
Expense Ratio  | 2.19  | 2.26  | 
NAV  | ₹10.38  | ₹168.01  | 
Fund Started  | 02 Jul 2025  | 13 Oct 2005  | 
Fund Size  | ₹903.43 Cr  | ₹1374.33 Cr  | 
Exit Load  | Exit load of 1%, if redeemed within 365 days  | Exit load of 1% if redeemed within 15 days.  | 
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year  | -  | 5.10%  | 
3 Year  | -  | 20.15%  | 
5 Year  | -  | 24.39%  | 
1 Year
3 Year
5 Year
Equity  | 97.85%  | 95.01%  | 
Cash  | 2.15%  | 4.99%  | 
Equity
Cash
Top 10 Holdings  | 
  | 
  | 
Top 10 Holdings
Name  | Assets  | 
|---|---|
HDFC Bank Ltd.  | 6.17%  | 
ICICI Bank Ltd.  | 4.24%  | 
Reliance Industries Ltd.  | 3.97%  | 
Infosys Ltd.  | 3.13%  | 
Kaynes Technology India Ltd.  | 2.58%  | 
Bharat Electronics Ltd.  | 2.44%  | 
Godfrey Phillips India Ltd.  | 2.37%  | 
AU Small Finance Bank Ltd.  | 2.21%  | 
Glaxosmithkline Pharmaceuticals Ltd.  | 2.20%  | 
Bharti Airtel Ltd.  | 2.14%  | 
Name  | Assets  | 
|---|---|
Infosys Ltd.  | 8.83%  | 
ICICI Bank Ltd.  | 6.77%  | 
Reliance Industries Ltd.  | 6.47%  | 
HDFC Bank Ltd.  | 5.24%  | 
NTPC Ltd.  | 4.83%  | 
Bharti Airtel Ltd.  | 4.81%  | 
Larsen & Toubro Ltd.  | 4.31%  | 
Sun Pharmaceutical Industries Ltd.  | 3.59%  | 
Dr. Reddy's Laboratories Ltd.  | 3.04%  | 
Tata Consultancy Services Ltd.  | 2.94%  | 
Name  | Dwijendra Srivastava  | Sri Sharma  | 
Start Date  | 02 Jul 2025  | 30 Apr 2021  | 
Name
Start Date
Description  | The scheme seeks to provide long-term capital growth to its Unitholders by following a multi factor based investment strategy.  | The scheme seeks to generate capital appreciation and income distribution to unit holders by investing predominantly in equity/equity related securities of the companies belonging to Exports & Services industry.  | 
Launch Date  | 02 Jul 2025  | 13 Oct 2005  | 
Description
Launch Date